Preeclampsia (PE), a hypertensive disease affecting 5-8% of pregnancies, 1 is a multisystem disorder, with vascular dysfunction being central to the disease. The heterogeneity of PE's signs and symptoms has generated controversy regarding whether the cause of PE is mainly related to maternal or placental factors (Supplemental Tables S1, S2). 2 Most researchers agree that placental hypoxia and/or oxidative stress plays an important role in the pathophysiology of PE, leading to a cascade of downstream effects. 3-5 The maternal cerebral vasculature is highly vulnerable to adverse effects of PE. Short-and long-term cerebrovascular complications of PE include posterior reversible encephalopathy syndrome (PRES), reversible cerebral vasoconstriction syndrome (RCVS), hemorrhagic and ischemic stroke, cerebral small vessel disease, and vascular dementia. 6-10 This review summarizes current evidence and recent advances in our understanding of the effects of PE on cerebrovascular disease in women, and outlines gaps in knowledge and directions for future research. Epidemiology of preeclampsia-associated cerebrovascular disease. PE is a leading cause of maternal morbidity and mortality worldwide. 11 In African-Americans, PE has a higher prevalence and is more likely to be associated with maternal complications, including 3-fold higher mortality rates. 12,13 Cerebrovascular disease is the leading cause of maternal mortality in women with PE, with the majority of deaths due to intracerebral hemorrhage (ICH). 14-17 In the United States (US), maternal stroke accounted for 7.4 percent of maternal deaths from 2011-2014. 18 Rates of antepartum and postpartum stroke, highly associated with PE, increased 47 and 83 percent, respectively, from 1994-1995 to 2006-2007 in the US. 19 This has been directly attributed to increasing rates of PE. 19,20 PE increases the risk of maternal stroke up to 6-fold. 7,21 Risk factors for peripartum stroke in women with PE include older age, African American race, chronic preexisting hypertension, underlying prothrombotic or inflammatory disorders, and infections. 22